Ada H. C. Kung

1.2k total citations
26 papers, 752 citations indexed

About

Ada H. C. Kung is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ada H. C. Kung has authored 26 papers receiving a total of 752 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ada H. C. Kung's work include Immune Response and Inflammation (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Ada H. C. Kung is often cited by papers focused on Immune Response and Inflammation (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Toxin Mechanisms and Immunotoxins (7 papers). Ada H. C. Kung collaborates with scholars based in United States and Argentina. Ada H. C. Kung's co-authors include W. S. Ammons, David Loury, John C. Fiddes, Fang Cheng, D. A. Steinberg, Dianne M. Fishwild, Susan L. Bernhard, Robert J. Bauer, Joachim L. Weickmann and Georgia Theofan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Blood.

In The Last Decade

Ada H. C. Kung

26 papers receiving 690 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ada H. C. Kung United States 14 358 358 337 72 69 26 752
M Tsujimoto Japan 20 429 1.2× 171 0.5× 520 1.5× 78 1.1× 20 0.3× 55 1.2k
Wolfgang Strittmatter Germany 14 410 1.1× 238 0.7× 321 1.0× 49 0.7× 26 0.4× 19 888
Bep Ravensbergen Netherlands 10 332 0.9× 392 1.1× 334 1.0× 58 0.8× 18 0.3× 11 868
C G Wilde United States 8 308 0.9× 339 0.9× 493 1.5× 37 0.5× 34 0.5× 9 821
Edie Dullaghan Canada 9 316 0.9× 304 0.8× 194 0.6× 62 0.9× 24 0.3× 12 741
J Y Homma Japan 21 611 1.7× 149 0.4× 565 1.7× 203 2.8× 86 1.2× 68 1.2k
N M Kelly Canada 13 273 0.8× 234 0.7× 413 1.2× 17 0.2× 89 1.3× 20 835
J M Willers Netherlands 17 285 0.8× 55 0.2× 325 1.0× 65 0.9× 42 0.6× 43 738
J L Snable United States 7 298 0.8× 346 1.0× 491 1.5× 38 0.5× 34 0.5× 9 807
Tobias Hertlein Germany 19 428 1.2× 196 0.5× 128 0.4× 61 0.8× 64 0.9× 35 829

Countries citing papers authored by Ada H. C. Kung

Since Specialization
Citations

This map shows the geographic impact of Ada H. C. Kung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada H. C. Kung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada H. C. Kung more than expected).

Fields of papers citing papers by Ada H. C. Kung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ada H. C. Kung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada H. C. Kung. The network helps show where Ada H. C. Kung may publish in the future.

Co-authorship network of co-authors of Ada H. C. Kung

This figure shows the co-authorship network connecting the top 25 collaborators of Ada H. C. Kung. A scholar is included among the top collaborators of Ada H. C. Kung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ada H. C. Kung. Ada H. C. Kung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miranda, Les P., Haiyan Shao, Shiah-Yun Chen, et al.. (2007). A Chemical Approach to the Pharmaceutical Optimization of an Anti-HIV Protein. Journal of the American Chemical Society. 129(43). 13153–13159. 11 indexed citations
2.
Chen, Shiah-Yun, Sonya Cressman, Feng Mao, et al.. (2005). Synthetic Erythropoietic Proteins: Tuning Biological Performance by Site-Specific Polymer Attachment. Chemistry & Biology. 12(3). 371–383. 36 indexed citations
3.
Fishwild, Dianne M., Darryl Hudson, Usha Deshpande, & Ada H. C. Kung. (1999). Differential Effects of Administration of a Human Anti-CD4 Monoclonal Antibody, HM6G, in Nonhuman Primates. Clinical Immunology. 92(2). 138–152. 17 indexed citations
4.
5.
Henck, Judith, Joy Cavagnaro, Andrew G. Hendrickx, et al.. (1996). Reproductive toxicity testing of therapeutic biotechnology agents. Teratology. 53(3). 185–195. 23 indexed citations
6.
Bauer, Robert J., Scott D. Leigh, C Birr, et al.. (1996). ALTERATION OF THE PHARMACOKINETICS OF SMALL PROTEINS BY IODINATION. Biopharmaceutics & Drug Disposition. 17(9). 761–774. 14 indexed citations
7.
9.
Better, Marc, Susan L. Bernhard, Robert E. Williams, et al.. (1995). T Cell-targeted Immunofusion Proteins from Escherichia coli. Journal of Biological Chemistry. 270(25). 14951–14957. 9 indexed citations
10.
Ammons, W. S., et al.. (1994). Protective Effects Of An N-Terminal Fragment Of Bactericidal/Permeability-Increasing Protein In Rodent Models Of Gram-Negative Sepsis: Role Of Bactericidal Properties. The Journal of Infectious Diseases. 170(6). 1473–1482. 30 indexed citations
11.
Carroll, Stephen F., et al.. (1994). Enhanced Stability in vitro and in vivo of Immunoconjugates Prepared with 5-Methyl-2-iminothiolane. Bioconjugate Chemistry. 5(3). 248–256. 12 indexed citations
13.
Elsbach, Peter, Jerrold Weiss, Martin E. Doerfler, et al.. (1994). The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.. PubMed. 388. 41–51. 12 indexed citations
14.
Kung, Ada H. C., et al.. (1994). Continuous Infusion Animal Model for the Immunoconjugate Xomazyme-CD5 Plus, in the Rat. Journal of the American College of Toxicology. 13(1). 64–75. 2 indexed citations
16.
Kung, Ada H. C., R Baughman, & James W. Larrick. (1993). Therapeutic proteins : pharmacokinetics and pharmacodynamics. 12 indexed citations
17.
Fishwild, Dianne M., et al.. (1993). Efficacy of anti-CD5 F(AB′)2 and FAB′ immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mice. International Journal of Immunopharmacology. 15(8). 871–878. 4 indexed citations
18.
Fishwild, Dianne M., et al.. (1993). Efficacy of an anti-CD5-ricin a chain immunoconjugate in an improved human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mouse model. International Journal of Immunopharmacology. 15(6). 695–709. 3 indexed citations
19.
Ammons, W. S., Arnold H. Horwitz, Lynn S. Grinna, et al.. (1993). Protective Effect of a Recombinant Amino-Terminal Fragment of Bactericidal/Permeability-Increasing Protein in Experimental Endotoxemia. The Journal of Infectious Diseases. 168(5). 1307–1310. 66 indexed citations
20.
Ammons, W. S. & Ada H. C. Kung. (1993). Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin.. PubMed. 41(3). 176–84. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026